Chemed CorporationCHENYSE

|||

Overview Charts News Fundamentals Key Metrics TTM Financials Earnings Growth Rating Analysts Institutional Peers Historical

Analyst Sentiment

Analysts lean bullish — 56% recommend buying.

Consensus Rating

Buy

9 analysts·Limited coverage

56%

Rating Distribution

Strong Buy

00%

Buy

556%

Hold

444%

Sell

00%

Strong Sell

00%

Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.

Price Target Expectations

Analysts see modest upside — consensus target 9% higher.

Bear Case

$475.00

+9%

Consensus

$475.00

+9%

Bull Case

$475.00

+9%

Price Range9 analysts

Low

Consensus

High

$475.00

Current Target

Current Price

$435.27

Upside to Target

$39.73

Price targets are 12-month forecasts. Actual results depend on earnings, market conditions, and sector trends.

Earnings & Revenue Estimates

2026E$25.41(2 analysts)

P/E23x

Current: 22.7x

Actual

Estimate

Range (Low–High)

Stock Alarm Pro

Forward Growth Estimates (YoY)

FY2027

Rev+4.21%

EPS+7.77%

FY2028

Rev+4.76%

EPS+8.67%

Earnings Surprises

Beat rate:42%(5/12 quarters)

Avg surprise:-1.2%

Beat

Miss

Inline

Estimate

Based on reported EPS vs consensus estimate.

Recent Analyst Actions

Jan 22, 2026Jefferies

Jefferies Downgrades Chemed (CHE) to Hold

Target:$475.00

+4.7%from $453.53

Sep 2, 2025Jefferies

Chemed upgraded to Buy from Hold at Jefferies

Target:$550.00

+18.5%from $464.00

Nov 5, 2024RBC Capital

Chemed (CHE) PT Lowered to $633 at RBC Capital

Target:$633.00

+18.4%from $534.41

May 21, 2024RBC Capital

Chemed (CHE) PT Lowered to $697 at RBC Capital

Target:$697.00

+23.5%from $564.34

Apr 28, 2022RBC Capital

RBC Capital Maintains Outperform on Chemed, Raises Price Target to $592

Target:$592.00

+20.3%from $492.25

Explore More

S&P 500 Screener

Filter and sort all 500 stocks

Market Movers

Today's biggest gainers and losers

Market Heatmap

Visual sector performance